IL-6 anticorps (AA 30-212) (FITC)

N° du produit ABIN7156924

Cet anticorps anti-IL-6 est un anticorps Lapin Polyclonal détectant IL-6 dans . Adapté pour Humain.

Aperçu rapide pour IL-6 anticorps (AA 30-212) (FITC) (ABIN7156924)

Antigène: IL-6 (IL6) (Interleukin 6 (IL6))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp IL-6 est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Détail du produit anti-IL-6 anticorps (FITC)

Épitope: AA 30-212

Fonction: IL6 Antibody, FITC conjugated

Purification: Protein G purified

Pureté: >95 %

Immunogène: Recombinant Human Interleukin-6 protein (30-212AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur IL-6

Antigène: IL-6 (IL6) (Interleukin 6 (IL6))

Autre désignation: IL6

Sujet: Interleukin BSF 2 antibody, B cell differentiation factor antibody, B cell stimulatory factor 2 antibody, B-cell stimulatory factor 2 antibody, BSF 2 antibody, BSF-2 antibody, BSF2 antibody, CDF antibody, CTL differentiation factor antibody, Cytotoxic T cell differentiation factor antibody, Hepatocyte stimulating factor antibody, Hepatocyte stimulatory factor antibody, HGF antibody, HSF antibody, Hybridoma growth factor antibody, Hybridoma growth factor Interferon beta-2 antibody, Hybridoma plasmacytoma growth factor antibody, IFN-beta-2 antibody, IFNB2 antibody, IL 6 antibody, IL-6 antibody, IL6 antibody, IL6_HUMAN antibody, Interferon beta 2 antibody, Interferon beta-2 antibody, Interleukin 6 antibody, Interleukin 6 (interferon beta 2) antibody, Interleukin BSF 2 antibody, Interleukin-6 antibody

UniProt: P05231

Pathways: Signalisation TLR, Hormone Transport, Negative Regulation of Hormone Secretion, Myometrial Relaxation and Contraction, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Regulation of Carbohydrate Metabolic Process, Autophagy, Cell RedoxHomeostasis, Cancer Immune Checkpoints, Inflammasome